Company Overview and News

0
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-06-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

40
CANADA STOCKS-TSX edges lower as energy shares drag

2018-06-12 reuters
June 12 (Reuters) - Canada’s main stock index edged lower on Tuesday as energy shares fell after OPEC cited a high degree of uncertainty regarding the global oil market this year.
TAHO TWMJF ACB THO WEED ACBFF PBA CGC SU SU

0
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

0
Pembina Pipeline: Delivering Growth By Building Up Canadian Infrastructure

2018-06-05 seekingalpha
The company has delivered growth on both an absolute and a per share basis over the past ten years.
PBA

14
Methanex Corporation Appoints Maureen Howe to Its Board of Directors

2018-06-04 globenewswire
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (NASDAQ:MEOH) is pleased to announce the appointment of Maureen Howe to its Board of Directors.
MX ABCO PBA MEOH

62
MLPs: Differentiated Performance

2018-06-03 seekingalpha
Midstream and MLPs synched up this week to rally 2.7%, outperforming the S&P 500 and utilities, despite renewed oil price angst this week. Midstream stocks and MLPs resumed their recovery after last week's pause, and have now posted gains in 7 of the last 10 weeks. After bottoming in late March, the AMZ and AMEI have posted total returns of 16.2% and 12.3%, respectively. The rally has helped the MLP Index break back into positive territory year-to-date, and the MLP Index closed the week almost exactly at its 200-day moving average (269.
NGL CQP CVI NGL.PRB KMI.WS ENB TGP NSH KMI.PRA KMI WMB EBBNF KMR CVB TRP LNG TGP.PRA TGP.PRB ENB ETP GMLP GLP ENBL NS PBA PAGP EPD WGP SPB CEQP TRP AMGP OKE PAA ENBBF KEYUF ENLK ENLC NS.PRC NS.PRB TCP DM CVRR SEMG KRP SUUIF KMRFZ NS.PRA

15
[Opinion] Gas Pipeline Infrastructure Market to Accrue Maximum Revenue Via Onshore Applications Over 2017-2024, U.S. to Majorly Contribute Toward the Regional Demand

2018-05-31 oilvoice
The latest buzz that the U.S. gas pipeline infrastructure market is ablaze with is Williams Pipeline Partners' approval application for its Transco natural gas pipeline project with FERC (Federal Energy Regulatory Commission). The former, a key provider of energy infrastructure in the U.S., aims to fulfill the escalating requirement for natural gas in Northeastern U.S. In addition, the project is anticipated to meet the surging demand for heat & power generation across states such as New York and New Jersey.
DPM DCP GEC GE GNE DCP.PRB PBA APA

4
Enbridge And Pembina May Soon Approve Major Pipeline Expansion

2018-05-30 seekingalpha
Going over the Alliance Pipeline, a major gas takeaway option for upstream players in B.C., Alberta, and North Dakota.
ENB ENBBF CVX EBBNF ENB PBA

50
CSX Recognizes 64 Customers with Chemical Safety Excellence Award

2018-05-29 globenewswire
JACKSONVILLE, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ:CSX) recently recognized 64 customers for their commitment to the safe transportation of hazardous materials with CSX’s annual Chemical Safety Excellence Award.
INGR NGL MOS HES KMI.WS NGL.PRB CVXTY ARKAF HUSKF MPC HES.PRA HSE AKE KMI.PRA KMI CSX GFGY ARKAY KMR CVB GEI CVVTF GBNXF CVX CRDE MOS.PRM ADM PBA KMRFZ

0
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-05-29 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

5
US LNG, Ethanol Sellers Buoyed By China Trade Talks

2018-05-22 rigzone
May 22 (Reuters) - China's interest in reducing its trade surplus with the United States through increased energy imports could advance plans for U.S. liquefied natural gas (LNG) plants and ethanol sales, said analysts and energy executives involved in developing new LNG facilities.
SRE.PRA CQP LNG SRE PBA

11
For Sale: Stalled Pipeline Project, Protesters Included

2018-05-18 rigzone
As Kinder Morgan Inc. drives a hard bargain in Canada’s attempt to save the Houston-based company’s embattled Trans Mountain project, the prime minister could end up fighting for an asset that hardly anybody wants. Pipeline giant Enbridge Inc., for one, signaled it doesn’t.
ENB ENBBF TRP KMI.PRA KMI KMI.WS EBBNF ENB KMR PBA CVB KMRFZ

11
For sale: stalled pipeline project, angry protesters included

2018-05-18 worldoil
As Kinder Morgan Inc. drives a hard bargain in Canada’s attempt to save the Houston-based company’s embattled Trans Mountain project, the prime minister could end up fighting for an asset that hardly anybody wants. Pipeline giant Enbridge Inc., for one, signaled it doesn’t.
ENB ENBBF TRP KMI.PRA KMI KMI.WS EBBNF ENB KMR PBA CVB KMRFZ

18
A windfall for government and a pain for consumers; the winners and losers of higher oil prices

2018-05-17 cbc.ca
Oil prices haven't been this high since late 2014 — a gusher of revenues for government and Canada's big energy companies, but consumers are feeling the pinch.
HSE KMI.PRA ACDVF KMI KMI.WS CNQ HUSKF KMR KMRFZ PBA CVB AC

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 706327103